Vaccines MDPI

Vaccines MDPI Vaccines is an international, peer-reviewed, open access journal. Published monthly online by MDPI.

📣 Check out the highly viewed review "Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishman...
25/09/2025

📣 Check out the highly viewed review "Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis"

✍️ By Andrea Lafleur, Stephane Daffis, Charles Mowbray and Byron Arana

👉 Access for free: https://brnw.ch/21wW5xC

Cutaneous leishmaniasis (CL), caused by protozoan parasites of the Leishmania genus, is prevalent in tropical and subtropical regions, with important morbidity, particularly in low- to middle-income countries. Current systemic treatments, including pentavalent antimonials and miltefosine, are associ...

  The 1st International Online Conference by Antibodies (https://brnw.ch/21wW5fI)🗓️ 13–14 October 2025 (Central European...
25/09/2025

The 1st International Online Conference by Antibodies (https://brnw.ch/21wW5fI)

🗓️ 13–14 October 2025 (Central European Time)

📣 Join us for the first online international conference organised by MDPI’s Antibodies on "Therapeutic Antibodies: New Trends in Discovery, Developability and Characterization"

📅 Important Dates to Remember:
- Registration Deadline: October 09, 2025

The event is chaired by Professor Arne Skerra and will cover the following topics:
S1: Antibody Discovery and Engineering;
S2: Antibody-based Therapeutics;
S3: Immuno-oncology and Tumor Imaging;
S4: Humoral Immunity;
S5: Computational Antibody Engineering.

👉 For more information or to register please visit: https://brnw.ch/21wW5fI

The 1st International Online Conference by Antibodies - Therapeutic Antibodies: New Trends in Discovery, Developability and Characterization

📣 We would like to share the newly published review "From Antibodies to Immunity: Assessing Correlates of Flavivirus Pro...
25/09/2025

📣 We would like to share the newly published review "From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity"

✍️ By Hannah E. Flores, Eduar Fernando Pinzon Burgos, Sigrid Camacho Ortega, Alonso Heredia and Joel V. Chua

🌎 From the Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, USA

👉 Read the full article here: https://brnw.ch/21wW4Yp

Flaviviruses are arthropod-borne RNA viruses that can cause a wide range of human diseases, from mild symptoms to severe illness with multiorgan failure and death. Effective prevention of these diseases relies on identifying reliable vaccine targets, typically measured by correlates of protection (C...

⏰Reminder: Applications are open for The Vaccines Travel AwardWe welcome applications from junior scientists who would l...
25/09/2025

⏰Reminder: Applications are open for The Vaccines Travel Award

We welcome applications from junior scientists who would like to present their latest research at academic conferences in 2026 within the field of laboratory and clinical vaccine research, utilization and immunization.

🗓 Deadline for nominations: 31 October 2025

👉 To apply or for more details please visit:
https://brnw.ch/21wW4HV

Vaccines, an international, peer-reviewed Open Access journal.

  🎨📑 "Buccal Administration of a Zika Virus Vaccine Utilizing 3D-Printed Oral Dissolving Films in a Mouse Model"✍️ Sarth...
25/09/2025

🎨

📑 "Buccal Administration of a Zika Virus Vaccine Utilizing 3D-Printed Oral Dissolving Films in a Mouse Model"

✍️ Sarthak Shah, Parth Patel, Amarae Ferguson, Priyal Bagwe, Akanksha Kale, Emmanuel Adediran, Revanth Singh, Tanisha Arte, Dedeepya Pasupuleti, Mohammad N. Uddin and Martin D’Souza from Mercer University, Atlanta, USA

👉 You can access the full text for free here: https://brnw.ch/21wW4us

Over the years, research regarding the Zika virus has been steadily increasing. Early immunization for ZIKV is a priority for preventing complications such as microencephaly and Guillain–Barré syndrome (GBS). Unlike traditional vaccination approaches, oral dissolving films (ODFs) or mucoadhesive ...

📣 We would like to share the highly cited article "Zika Vaccine Microparticles (MPs)-Loaded Dissolving Microneedles (MNs...
24/09/2025

📣 We would like to share the highly cited article "Zika Vaccine Microparticles (MPs)-Loaded Dissolving Microneedles (MNs) Elicit a Significant Immune Response in a Pre-Clinical Murine Model"

✍️ By Akanksha Kale, Devyani Joshi, Ipsh*ta Menon, Priyal Bagwe, Smital Patil, Sharon Vijayanand, Keegan Braz Gomes, Mohammad N. Uddin and Martin J. D’Souza from Vaccine Nanotechnology Laboratory, Center for Drug Delivery and Research, Mercer University College of Pharmacy, USA

👉 Access for free: https://brnw.ch/21wW3rK

Although the global Zika epidemic in 2015–16 fueled vaccine development efforts, there is no approved Zika vaccine or treatment available to date. Current vaccine platforms in clinical trials are administered via either subcutaneous or intramuscular injections, which are painful and decrease compl...

📣 Read papers from the highly cited Special Issue"Immune Correlates of Protection in Vaccines" 👤 Guest Editor: Dr. Jingy...
24/09/2025

📣 Read papers from the highly cited Special Issue

"Immune Correlates of Protection in Vaccines"

👤 Guest Editor: Dr. Jingyou Yu

This Special Issue aimed to enrich our knowledge of immune responses, elicited naturally or by vaccination, and their contribution to protective efficacy.

👉 Access the papers for free here: https://brnw.ch/21wW3bD

Vaccines, an international, peer-reviewed Open Access journal.

📣 We would like to share the newly published article "Adjuvanted RNA Origami—A Tunable Peptide Assembly Platform for Con...
24/09/2025

📣 We would like to share the newly published article "Adjuvanted RNA Origami—A Tunable Peptide Assembly Platform for Constructing Cancer Nanovaccines"

✍️ By Theresa Yip, Xinyi Tu, Xiaodong Qi, Hao Yan and Yung Chang

👉 Read the full article here: https://brnw.ch/21wW2Wm

Background/Objectives: Cancer peptide vaccines represent a promising strategy to develop targeted and personalized treatments for cancer patients. While tumor peptides alone are insufficient in mounting effective immune responses, the addition of adjuvants can enhance their immunogenicity. Nanoparti...

🖥️ Join us for MDPI Webinar | The Science Behind the Prize: 2025 Nobel Physiology or Medicine Roundtable📅 Date: 6 Octobe...
24/09/2025

🖥️ Join us for MDPI Webinar | The Science Behind the Prize: 2025 Nobel Physiology or Medicine Roundtable

📅 Date: 6 October 2025
🕘 3:30 p.m. CEST | 9:30 a.m. EDT | 9:30 p.m. CST (Asia)
🆔 Webinar ID: 852 3554 5031

This webinar underscores the importance of recognizing outstanding achievements that push the boundaries of human knowledge and understanding. It represents a valuable opportunity to exchange ideas on the advancements driving scientific progress and to inspire the next generation of gifted scientists.

🚀 Register now for free! 👉 https://brnw.ch/21wW2G2

👉 Please find the schedule and speaker list here: https://brnw.ch/21wW2G3

Coinciding with the announcement of the 2025 Nobel Prize in physiology or medicine, this forum underscores the importance of recognizing...

  🎨📑 "Vaccination with a Protective Ipa Protein-Containing Nanoemulsion Differentially Alters the Transcriptomic Profile...
24/09/2025

🎨

📑 "Vaccination with a Protective Ipa Protein-Containing Nanoemulsion Differentially Alters the Transcriptomic Profiles of Young and Elderly Mice following Shigella Infection"

✍️ Ti Lu, Murugesan Raju, Debaki R. Howlader, Zackary K. Dietz, Sean K. Whittier, David J. Varisco, Robert K. Ernst, Lyndon M. Coghill, William D. Picking and Wendy L. Picking

👉 You can access the full text for free here: https://brnw.ch/21wW2r2

Shigella spp. are responsible for bacillary dysentery or shigellosis transmitted via the fecal–oral route, causing significant morbidity and mortality, especially among vulnerable populations. There are currently no licensed Shigella vaccines. Shigella spp. use a type III secretion system (T3SS) t...

📣 Check out the highly viewed review "Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment" ✍...
23/09/2025

📣 Check out the highly viewed review "Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment"

✍️ By Jarrett Lopez-Scarim, Shashank Manohar Nambiar and Eva Billerbeck from Division of Hepatology, Department of Medicine and Department of Microbiology and Immunology, Albert Einstein College of Medicine, USA

👉 Access for free: https://brnw.ch/21wW1kx

T cells play an important role in the clearance of hepatotropic viruses but may also cause liver injury and contribute to disease progression in chronic hepatitis B and C virus infections which affect millions of people worldwide. The liver provides a unique microenvironment of immunological toleran...

📢 Call for Papers"Streptococcal Vaccines: Current Status and Future Directions"👤Guest Editor: Dr. Mariusz Skwarczynski🗓️...
23/09/2025

📢 Call for Papers

"Streptococcal Vaccines: Current Status and Future Directions"

👤Guest Editor: Dr. Mariusz Skwarczynski

🗓️ Manuscript Submission Deadline: 31 July 2026

In this Special Issue, original research articles and reviews are welcome and may include the following topics:
- Vaccine development against Group A or B Streptococcus;
- Vaccines targeting other Streptococcal species;
- Adjuvants in streptococcal vaccines;
- Animal models for streptococcal vaccines;
- Clinical trials on the Streptococcal vaccines.

👉 For more information and to submit your manuscript, please visit: https://brnw.ch/21wW12H

Vaccines, an international, peer-reviewed Open Access journal.

Adresse

Basel

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Vaccines MDPI erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Service Kontaktieren

Nachricht an Vaccines MDPI senden:

Teilen

Kategorie